Submit your resume today!
Researchers have discovered a unique #biomarker common to multiple #cancers. This may come as a breakthrough for cancer diagnosis, which is generally extremely variable w/ different cancers possessing different signatures: https://t.co/RcK0MgSz3E via @BioanalysisZone
BioAgilytix Europe's Dr. Arno Kromminga fielded some excellent questions from attendees of his recent #immunogenicity #webinar. He recaps & expands upon several of those answers in our latest blog: https://t.co/rLxuEJS6k3
The latest issue of Bioanalysis includes a Panel Discussion Report on 'The business of Bioanalysis: New Technology integration into bioanalytical workflows' by BioAgilytix's Afshin Safavi and other industry influencers. Access it here: https://t.co/46nx2RtUCk
BioAgilytix Europe is seeking a Quality Assurance (#QA) Engineer to join our team in Hamburg, Germany. Learn more about this position here: https://t.co/j6ucqjUrGN #hiring #scientificjobs
WRAL TechWire recently covered BioAgilytix’s acquisition by Cobepa. The article discusses the benefits of the new partnership for both organizations moving forward. Read more here: bit.ly/2ApwID3
Belgian investment company acquires Durham biotesting firm BioAgilytix | WRAL TechWire
wraltechwire.com
Durham-based BioAgilytix, a fast-growing provider of bioanalytical testing services for large-molecule drugs, will be acquired by a privately held Belgian investment company.Our team had the opportunity to both attend and present at a number of content-rich sessions during AAPS’ 2018 PharmSci 360 event. These conversations will have a direct impact on our own work moving forward, and we wanted to summarize and share a few of the key takeaways we found most interesting and valuable: bit.ly/2DZZJJR
Key Takeaways from 2018’s AAPS PharmSci 360 Annual Meeting
bioagilytix.com
We summarize and share a few of the key takeaways we found most interesting and valuable from AAPS’ 2018 PharmSci 360 event.What makes BioAgilytix a different kind of bioanalytical CRO? It’s in the way we deliver premium science to support complex large molecule drug discovery and development. #TheBioAgilytixWay
Services
Platforms
